Two diagnostics companies announced they will be able to advance their cancer portfolio with new funding. Baltimore-based Personal Genome Diagnostics Inc. announced it raised $103m in a series C financing round and Cleveland Diagnostics announced it raised $17.4m in a series D round.
Personal Genome Diagnostics announced on 10 February it raised $103m in a
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?